Targets for Cancer IO: A Deep Dive Series

The Society for Immunotherapy of Cancer (SITC) is pleased to offer a second highly anticipated series of nine live webinars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format.

Program Organizers

Register Here

Live Webinar 1 – LAG-3 Biology and current clinical Results

• Date of Live Event: Monday, June 13, 2022 – 12 p.m.–2 p.m. CDT
• Moderators:
  • Drew M. Pardoll, MD, PhD – Johns Hopkins University
  • Dario A.A. Vignali, PhD – University of Pittsburgh
• Faculty:
  • Tullia C. Bruno, PhD – University of Pittsburgh
  • Evan J. Lipson, MD – Johns Hopkins University
  • Dario A.A. Vignali, PhD – University of Pittsburgh

Live Webinar 2 – Recombinant Interleukin-18 Immunotherapy

• Date of Live Event: Monday, July 18, 2022 – 11 a.m.–1 p.m. CDT
• Moderators:
  • Michael T. Lotze, MD, FACS – Nurix Therapeutics
  • Aaron M. Ring, MD, PhD – Yale University School of Medicine
• Faculty:
  • TBD

Live Webinar 3 –TIL Therapies

• Date of Live Event: Thursday, July 28, 2022 – 12 p.m.–2 p.m. CDT
• Moderators:
  • Brian R. Gastman, MD – Cleveland Clinic Cancer Center
    
  • Stephanie L. Goff, MD, FACS – National Cancer Institute Surgery Branch
• Faculty:
  • TBD

Live Webinar 4 – Targeted systemic delivery of innate immune activators

• Date of Live Event: Friday, Aug. 26, 2022 – 10 a.m.–12 p.m. CDT
• Moderators:
  
  • Timothy Lowinger, PhD – Mersana Therapeutics
  • Valerie Odegard, PhD – Silverback Therapeutics
• Faculty:
  
  • TBD
    

Live Webinar 5 – Scientific basis of B-cell modulation for anti-tumor immunity and reduction of ICI toxicity

• Date of Live Event: Thursday, Sept.15, 2022 – 12 p.m.–2 p.m. CDT
• Moderators:
  • Tullia C. Bruno, PhD – University of Pittsburgh
  • Daniel Hollern, PhD – The Salk Institute for Biological Studies
• Faculty:
  • TBD
    

Live Webinar 6 – iPSC derived cell therapies 

• Date of Live Event: Monday, Sept. 26, 2022 – 10 a.m.–12 p.m. CDT
• Moderators:
  • Kalle Malmberg, MD, PhD – Oslo University Hospital
  • Jeffrey S. Miller, MD – University of Minnesota
• Faculty:
  • TBD

Live Webinar 7 – Enhanced CTLA-4  blockade

• Date of Live Event: Wednesday, Oct. 5, 2022 – 1 p.m.–3 p.m. CDT
• Moderators:
  • James P. Allison, PhD, FAIO – The University of Texas MD Anderson Cancer Center
  • Alan J. Korman, PhD, FAIO – Vir Biotechnology
• Faculty:
  
  • TBD
    
    

Live Webinar 8 – TCR Based Therapeutics

• Date of Live Event: Wednesday, Dec. 7, 2022 – 2 p.m.–4 p.m. CST
• Moderators:
  
  • Harlan Robins, PhD – Adaptive Biotechnologies Corporation
  • Harpreet Singh, PhD – Immatics Biotechnologies GmbH
• Faculty:
  • TBD

Live Webinar 9 – NK cell engagers  

• Date of Live Event: Wednesday, Jan. 11, 2023 – 10 a.m.–12 p.m. CST
• Moderators:
  
  • Adelheid Cerwenka, PhD – Heidelberg University
  • Lewis L. Lanier, PhD – University of California, San Francisco
• Faculty:
  • TBD

Basic, clinical and translational researchers in academia and industry and members of the investment community.

View Registration Rates

All Deep Dive webinar recordings and slide content (contingent upon faculty permissions) will be posted in your SITC Library if you are registered for the seminar. To access the Enduring Materials, you must be logged into your SITC account.

View Enduring Materials

If you have questions about this webinar series, please contact the SITC Education team.

Targets for Cancer IO: A Deep Dive Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, Merck & Co., Inc., and Regeneron Pharmaceuticals (as of 10/05/2021).

Interested in supporting this program? The SITC Development team would love to work with you. Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.